These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18590702)

  • 1. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
    Kang MK; Kang SK
    Biochem Biophys Res Commun; 2008 Sep; 373(4):539-44. PubMed ID: 18590702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
    Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
    Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of the potential cancer stem-like cell marker Rex-1 improves chemotherapeutic effects in gliomas.
    Kim BS; Kang KS; Choi JI; Jung JS; Im YB; Kang SK
    Hum Gene Ther; 2011 Dec; 22(12):1551-62. PubMed ID: 21810014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells.
    Lee EL; Shimizu T; Ise T; Numata T; Kohno K; Okada Y
    J Cell Physiol; 2007 May; 211(2):513-21. PubMed ID: 17186499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.
    Kang MK; Kang SK
    Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
    Ng WH; Wan GQ; Too HP
    J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New light on the "old" chloride channel blocker DIDS.
    Wulff H
    ACS Chem Biol; 2008 Jul; 3(7):399-401. PubMed ID: 18642798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCO(3)(-)-independent rescue from apoptosis by stilbene derivatives in rat cardiomyocytes.
    Tanabe S; Wang X; Takahashi N; Uramoto H; Okada Y
    FEBS Lett; 2005 Jan; 579(2):517-22. PubMed ID: 15642369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic modulation of glioblastoma with dichloroacetate.
    Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
    Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy resistance of glioblastoma stem cells.
    Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
    Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
    [No Abstract]   [Full Text] [Related]  

  • 13. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT; Lee S; Yin GN; Mori K; Suk K
    J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid (DIDS) Ameliorates Ischemia-Hypoxia-Induced White Matter Damage in Neonatal Rats through Inhibition of the Voltage-Gated Chloride Channel ClC-2.
    Zhao B; Quan H; Ma T; Tian Y; Cai Q; Li H
    Int J Mol Sci; 2015 May; 16(5):10457-69. PubMed ID: 25961953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tumor stem cells as research and treatment targets.
    Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
    Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.
    Leweke F; Damian MS; Schindler C; Schachenmayr W
    Pathol Res Pract; 1998; 194(3):149-55. PubMed ID: 9587932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a chloride channel inhibitor and chloride-free medium on choriogonin-induced cAMP formation by Xenopus laevis follicles].
    Skoblina MN; Khukhtaniemi I
    Ontogenez; 1998; 29(3):178-80. PubMed ID: 9702794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the study of brain tumor stem cells as treatment targets].
    Hide T; Kuratsu J
    Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.